|
|
|
|
|
Title Story精选合集二 | MDPI Antibodies |
|
|
期刊名:Antibodies
期刊主页:https://www.mdpi.com/journal/antibodies
本期为您精选Antibodies期刊Title Story 文章合集系列二的7篇文章,希望能为相关领域学者提供新的思路和参考,欢迎阅读。
1. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies
基于片段的免疫细胞衔接抗体在癌症、传染病和自身免疫性疾病治疗中的应用:来自临床和转化研究的经验和见解
https://www.mdpi.com/2073-4468/14/3/52
Yang, G.; Massumi, M. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies. Antibodies 2025, 14, 52.

2. Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus
基于生成式深度学习的单域抗体设计,用于对抗委内瑞拉马脑炎病毒
https://www.mdpi.com/2073-4468/14/2/41
Liu, J.L.; Bayacal, G.C.; Alvarez, J.A.E.; Shriver-Lake, L.C.; Goldman, E.R.; Dean, S.N. Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus. Antibodies 2025, 14, 41.

3. Seroprevalence of IgG and IgE Antibodies Against Anisakis in the Presumably Healthy Population of the Canary Islands
加那利群岛健康人群中针对异尖线虫的IgG和IgE抗体血清阳性率
https://www.mdpi.com/2073-4468/14/3/60
González-Rodríguez, E.; Rodero, M.; Montoya-Alonso, J.A.; Santana-Hernández, K.M.; Ventura, M.R.; Cuéllar, C.; Rodríguez-Ponce, E. Seroprevalence of IgG and IgE Antibodies Against Anisakis in the Presumably Healthy Population of the Canary Islands. Antibodies 2025, 14, 60.

4. FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia
FcRn阻断作为抗体介导的自身免疫性疾病的靶向治疗策略:以温型自身免疫性溶血性贫血为例
https://www.mdpi.com/2073-4468/14/3/65
Sandhu, M.; Murakhovskaya, I. FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. Antibodies 2025, 14, 65.

5. Loss of IgA and IgM Compromises Broad Neutralization of Structurally Divergent SARS-CoV-2 Variants
IgA和IgM的缺失会削弱对结构不同的SARS-CoV-2变异株的广泛中和作用
https://www.mdpi.com/2073-4468/14/3/59
Pisil, Y.; Miura, T.; Ito, K.; Watanabe, Y. Loss of IgA and IgM Compromises Broad Neutralization of Structurally Divergent SARS-CoV-2 Variants. Antibodies 2025, 14, 59.

6. Computational Prediction of Single-Domain Immunoglobulin Aggregation Propensities Facilitates Discovery and Humanization of Recombinant Nanobodies
单域免疫球蛋白聚集倾向的计算预测有助于重组纳米抗体的发现和人源化
https://www.mdpi.com/2073-4468/14/3/73
Geyer, F.K.; Borbeck, J.; Palka, W.; Zhou, X.; Takimoto, J.; Rabinovich, B.; Reifenhäuser, B.; Friedrich, K.; Kolmar, H. Computational Prediction of Single-Domain Immunoglobulin Aggregation Propensities Facilitates Discovery and Humanization of Recombinant Nanobodies. Antibodies 2025, 14, 73.

7. Isolation of a Monoclonal Human scFv Against Cytomegalovirus pp71 Antigen Using Yeast Display
利用酵母展示技术分离抗巨细胞病毒pp71抗原的单克隆人scFv
https://www.mdpi.com/2073-4468/14/3/57
Aoki, K.; Yabe, R.; Ono, S.; Saeki, M.; Tanno, Y.; Tanno, H. Isolation of a Monoclonal Human scFv Against Cytomegalovirus pp71 Antigen Using Yeast Display. Antibodies 2025, 14, 57.

期刊介绍
主编:Arne Skerra, Technical University of Munich, Germany
期刊主题涵盖抗体和体液免疫反应、抗体的发现、产生和选择、抗体结构和功能、抗体工程、结合物和融合蛋白、生物医学研究和治疗中的抗体。
|
2024 Impact Factor
|
2.7
|
|
2024 CiteScore
|
4.5
|
|
Time to First Decision
|
19.5 Days
|
|
Acceptance to Publication
|
5.7 Days
|
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。